Orphazyme: CEO Kim Stratton presents at Orphan Drugs May 27

feed

view company updates

tools

perform investment research

network

join events & discussions

advisory

about us

Redeye Capital

Orphazyme: CEO Kim Stratton presents at Orphan Drugs May 27

May 27 2020

© All rights reserved. Redeye AB is authorised and regulated by the Swedish Financial Supervisory Authority, Finansinspektionen. 2024